Stock Ratings / Health Care / LFWD / earnings

HSCS (43) CUPR (32) CLGN (50) MLSS (43) ⌘ Pro Terminal →

Lifeward Ltd. (LFWD) Next Earnings Date & Expected ±11.9% Move

$5.91 +2.78% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Lifeward Ltd. (LFWD) carries a Roarable Rating of D (Sell) with 46/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $16.7M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERSELL / AVOID • D

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-5.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for LFWD)Realized 20D OHLCV Swing Band: ±11.9%

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±11.9% Swing Band

±$0.70 Expected Swing

MODEL EARNINGS SETUP GAUGE

LFWD Quantitative Pre-Earnings Setup: 46/100

Trailing EPS: $4.25 • YoY Revenue Growth: -17.6%

Model Bullish Setup (46/100)Model Risk Weight (54/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$1.4M	-$19.9M	-$16.8M	98%
FY 2024	2024-12-31	$1.7M	-$28.9M	-$21.7M	98%
FY 2023	2023-12-31	$435.0K	-$22.1M	-$20.7M	92%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring LFWD)

✓Walkthrough of LFWD's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

LFWD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -18.82%📐 HORIZONTAL RANGE

2026-10-30O $5.87H $6.10L $5.87C $5.91VOL 3.5K

RES: $8.00SUP: $4.47SMA50: $6.66SMA200: $6.96

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

LFWD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 LFWD Butterfly Map → + Track LFWD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -17.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on LFWD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for LFWD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for LFWD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (LFWD)

Health Care Rank #461 of 1016 ⚔️ HSCS vs LFWD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (LFWD vs. HSCS, CUPR, CLGN, MLSS)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Lifeward Ltd. (LFWD) ranks #461 by composite RQD confidence (46/100, grade D) and #848 by equity capitalization ($16.7M). Within this direct 5-issuer industry benchmark cohort, MLSS leads on earnings valuation at 5.0x trailing P/E, while LFWD leads on capital efficiency and profitability with -35.0% ROIC and 96.0% gross margin. CLGN currently holds the highest overall quantitative score in the immediate peer group at 50/100 (D) compared with LFWD at 46/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
LFWD ACTIVE Lifeward Ltd.	D	46/100	—	96.0%	-35.0%	+2.78%	$16.7M	Benchmark Subject
HSCS HeartSciences Inc.	D-	43/100	—	59.1%	-35.0%	+7.12%	$17.5M	/hscs-vs-lfwd →
CUPR Cuprina Holdings (Cayman) Limited (Class A)	E	32/100	—	-1.3%	-35.0%	-1.07%	$14.1M	/cupr-vs-lfwd →
CLGN CollPlant Biotechnologies Ltd	D	50/100	—	64.8%	-35.0%	+11.39%	$12.7M	/clgn-vs-lfwd →
MLSS Milestone Scientific Inc.	D-	43/100	5.0x	71.4%	-35.0%	-0.54%	$28.6M	/mlss-vs-lfwd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001607962

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Lifeward Ltd. (LFWD) reported GAAP revenue of $1.4M (-17.6% vs. FY2024 revenue of $1.7M , and +221.8% cumulative change since FY2023) , GAAP net income of -$19.9M, operating cash flow of -$16.8M, and free cash flow of -$16.8M (+22.5% YoY). On the balance sheet, LFWD closed FY2025 with $22.9M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.4M	-$19.9M	-$16.8M	-$16.8M	$22.9M	—
FY2024 (FY)	2024-12-31	$1.7M	-$28.9M	-$21.7M	-$21.7M	$30.5M	—
FY2023 (FY)	2023-12-31	$435.0K	-$22.1M	-$20.7M	-$20.7M	—	—

3. LFWD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is LFWD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Lifeward Ltd. (NASDAQ: LFWD) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $5.91 (+2.78% 1D, market cap $16.7M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, LFWD ranks #461 in composite RQD confidence.

How does LFWD compare to HSCS and CUPR in the Health Care sector?

Within the Health Care sector (Industrial Specialties), LFWD carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of 96.0%, and ROIC of -35.0%. By comparison, HSCS (HeartSciences Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $17.5M) and CUPR (Cuprina Holdings (Cayman) Limited (Class A)) posts a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $14.1M). Among the 5-stock peer group, MLSS leads on earnings multiple (5.0x) while LFWD leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for LFWD?

Per LFWD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001607962), Lifeward Ltd. generated $1.4M in revenue (-17.6% YoY), -$19.9M in net income, and -$16.8M in free cash flow against $22.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is LFWD trading relative to its 50-day, 200-day, and 52-week technical levels?

LFWD last traded at $5.91 (+2.78% on volume of 1,101 shares), positioning the stock -11.26% below its 50-day simple moving average ($6.66) and -15.09% below its 200-day simple moving average ($6.96). Across its 52-week range of $4.14 to $9.61, LFWD sits at the 32.4% percentile with a 14-day RSI of 44.8 (NEUTRAL RANGE) and an implied next-earnings move of ±11.9% ($5.21 to $6.61).